Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Vivos Therapeutics Inc (VVOS)

Vivos Therapeutics Inc (VVOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Vivos Therapeutics Inc 7921 SOUTHPARK PLAZA SUITE 210 LITTLETON CO 80120 USA

www.vivos.com Employees: 114 P: 844-672-4357

Description:

Vivos Therapeutics Inc. is a medical technology company. It engages in the development and commercialization of technology solutions for patients with sleep disordered breathing comprising mild-to-moderate obstructive sleep apnea. Vivos Therapeutics Inc. is based in Highlands Ranch, Colorado.

Key Statistics

Overview:

Market Capitalization, $K 15,473
Enterprise Value, $K 13,833
Shares Outstanding, K 4,835
Annual Sales, $ 13,800 K
Annual Net Income, $ -13,580 K
Last Quarter Sales, $ 3,860 K
Last Quarter Net Income, $ -2,620 K
EBIT, $ -12,070 K
EBITDA, $ -11,450 K
60-Month Beta 7.71
% of Insider Shareholders 3.00%
% of Institutional Shareholders 26.35%
Float, K 4,690
% Float 97.00%
Short Volume Ratio 0.58

Growth:

1-Year Return -19.80%
3-Year Return -95.17%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.40 on 11/14/24
Next Earnings Date 11/12/24
Earnings Per Share ttm -5.68
EPS Growth vs. Prev Qtr 33.33%
EPS Growth vs. Prev Year 77.14%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-25 on 10/27/23

VVOS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -335.04%
Return-on-Assets % -93.58%
Profit Margin % -98.41%
Debt/Equity 0.00
Price/Sales 1.03
Price/Cash Flow N/A
Price/Book 1.83
Book Value/Share 1.61
Interest Coverage -0.46
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar